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Introduction 
Asthma is the most common chronic disease in 
childhood, affecting over 10% of children below 15 
years of age in the U.K. (1,2). The number of hospital 
admissions has been rising steadily (3) and the 
prevalence appears to be increasing (4,5). There is 
evidence that many wheezy children are not being 
adequately treated and that prescribed therapy may 
not be used appropriately because of lack of under- 
standing by patients or their parents (1,6-12). The 
unpredictability of the course of the disease and 
difficulties in assessing patient compliance cause fur- 
ther problems in maintaining good control of the 
disease (13-15). In contrast with the situation in the 
early eighties, when there seemed to be no common 
specialist approach (16), recent consensus statements 
on the management of asthma in adults (17) and 
children (1819) now provide clear therapeutic 
guidelines. 
In view of these recent developments in the pub- 
lishing of asthma and its ideal therapy, we embarked 
upon a study of current treatment in children with 
unequivocal asthma, in three asthma clinics, which 
had been previously surveyed in 1979 and 1983. We 
were particularly interested in asthma treatment from 
the patients’ and parents’ perspectives, use of other 
therapy, and understanding of treatment. 
Patients and Methods 
Paediatric asthma clinics were surveyed at three 
London hospitals (Hammersmith, Kingston and The 
Hospitals for Sick Children). All were directed by 
consultant paediatricians with an interest in respira- 
tory disease and no changes in senior medical staff 
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had occurred since the first study in 1979. Only two 
criteria for inclusion were made, namely attendance 
on at least one previous occasion and the ability to 
speak English without an interpreter. Before giving 
permission to take part in the interview, the purpose 
of the survey was explained to parents and children 
and it was made clear that their replies would only be 
relayed to their medical attendants in an indirect 
form so as to ensure confidentiality. To promote an 
atmosphere where parents and children could speak 
freely and expand upon responses, one interviewer 
wrote down the replies, while the other conducted the 
interview without interruption. 
We used the same questionnaire as in 1979 and 
1983 which included demographic details, questions 
on treatment and on the home and school situation. 
Finally the various medications prescribed for each 
individual were discussed in detail. Knowledge of 
drug action was scored on a O-2 scale corresponding 
to none, partial or complete, using a selection of key 
concepts for each drug group. For example, the key 
concepts for P-agonists included brochodilator, 
absence of a prophylactic effect except before exercise 
and immediate relief. For corticosteroids the key 
concepts were anti-inflammatory activity, pro- 
phylactic role, absence of immediate relief and the 
importance of regular use. 
Patterns of treatment, age and sex distribution 
were compared between clinics and between surveys 
using chi squared analysis and, if no significant 
differences (P<O.O5) were demonstrated, data were 
aggregated for further analysis, 
Results 
Age and sex distribution were not significantly 
different from the two earlier surveys. Distribution of 
age and sex were also not significantly different 
between clinics. Age ranged between 1.2 and 15 1 yr 
with a mean age of approximately 7 yr, male: female 
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F’ig. 1 Major treatment patterns found in 1977, 1983 and 1991. All children using corticosteroids, theophylline and 
cromoglycate had access to p-adrenergic agonists, (except two children in the 1991 survey). In 1991, six using /?-adrenergic 
agonists, theophylline and corticosteroids were included in the steroid group. In 1977 and 1983, five and 10 patients 
respectively using cromoglycate and theophylline were included in the cromoglycate group. 
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Fig, 2 Distribution of parental/child responsibility for 
treatment by child age. In all three surveys most children 
over 10 years were responsible for their own treatment. 
ratio was 1.6: 1 and age of onset of symptoms 
ranged from 0.1 to 11.0 yr with a mean of 2 yr and 8 
months. 
The pattern of drug use had changed considerably 
over the 14 yr period (Fig. 1) with 82% taking at least 
two drugs in 1991, the commonest pattern (59%) 
being a P-agonist with a corticosteroid. Corticoster- 
oid use rose from 24% in the 1983 survey to 59% in 
the present survey. Nearly all steroids (95%) were 
administered by inhalation only, with only 5% being 
administered orally. The use of theophylline and 
cromoglycate fell from 50% in 1983 to 33%. As in 
1983 more than 50% (31% in 1977) reported occa- 
sional or regular use of general practitioner pre- 
scribed antibiotics during exacerbations of asthma. 
When asked about other therapy, two parents men- 
tioned menthol inhalation as a helpful treatment and 
three children were taking regular Ipratropium Bro- 
mide (Atrovent) and Terfenadine (Triludan). Below 
the age of 5 no child had free access to drugs. Above 
the age of 10 virtually all did (Fig. 2). One third of the 
children had a peak flow meter at home and of those 
taking their medicines at school 17% admitted to 
embarrassment. Only one-third regularly used pro- 
phylactic therapy prior to games. 
Most parents were happy with their level of knowl- 
edge about the treatment prescribed (55 of 65) and 
most were satisfied with the clinic doctor’s advice for 
management of mild episodes (49 of 65) and severe 
exacerbations (47 of 65). Twelve parents (18%) spon- 
taneously mentioned that they were unhappy with 
their general practitioners despite the fact that no 
leading question was posed on this subject. 
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Most children (85%) found no problem in taking common and misplaced emphasis on ‘wheezy 
the prescribed medication and those who did were bronchitis’ and bacterial infection (6,21,22). Surveys 
mostly in the younger age-groups. This dislike was of prescribing practice and patient use and under- 
frequently due to the mask and spacer device used for standing of therapy are useful in identifying areas of 
inhaled /I agonist and/or steroids. concern and changing attitudes to asthma. 
We found that 11 (17%) of the children or their 
parents had no idea of the mode of action of 
/?-agonists (in 1983, 35%). One-third could not say 
anything about the mode of action of corticosteroids, 
one third knew something and the remaining third 
had a good working knowledge of the benefits and 
possible side effects. 
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